Drug Approval | October 20, 2023
USFDA approves Pfizer’s Velsipity for adults with Ulcerative Colitis
Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials
Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials
hey were educated about the 7- step hand-washing technique trainings
Short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD)
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Glenmark's current portfolio consists of 188 products authorized for distribution in the US
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
He has 37 years of experience in API Intermediaries, Pharma and Chemicals industr
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
The new gummy capabilities include a dedicated R&D lab, an automated production line, and bottle packaging solutions
Subscribe To Our Newsletter & Stay Updated
